Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-801

Actually, no, I totally thought it possible that he misspoke. But what would it matter? He clearly meant efficacy, and it is bonkers to think he would have intentionally said efficiency, which makes no sense.

But nowhere did I say he intentionally said efficiency - as you say here.

Given a translation by reg with efficiency and sailing where efficacy and saline would have made sense I requested the source.

You wrote "OMG", "WTF" and suggested I was trolling, - those don't sound like you were keeping an even mannered and open disposition to the possibility that Phillip Krause might has just misspoken to me - at least that was not how I interpreted you comment to me.

I don't see that anything at all was lost by checking the sources - on the other hand - in a marketplace where some are given access to say what was said at the Bell Potter event and others are not and the market is trading something just potentially might be said that gave part of the market but not the rest some advantage couldn't it?